E

Erasca

Clinical-stage oncology company targeting RAS/MAPK pathway

Senior Vice President Clinical Development & Global Program Lead - Pancreatic Cancer

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeIn-person

About the Job

Requirements

  • An M.D. degree or equivalent, subspecialty fellowship training, and board certification or eligibility in Oncology or Oncology/Hematology are required.
  • At least 8 years of oncology clinical trial and drug development experience, including extensive pharmaceutical or biotechnology industry experience.
  • Experience as the clinical lead on late-stage clinical programs in colorectal, pancreatic, or other gastrointestinal cancers is required.
  • Experience leading or being closely involved in clinical aspects of a regulatory filing and direct interaction with health authorities is required.
  • Extensive knowledge of clinical trial methodology and the regulatory and compliance requirements governing clinical trials.
  • Ability to collaborate successfully with multiple functions in a matrixed team environment.
  • Executive leadership skills to educate and influence stakeholders and contribute value to strategic business planning and decision-making.
  • Effective interpersonal, communication, and influencing skills, including excellent writing skills and the ability to tailor communications to diverse audiences and situations.
  • Ability to achieve performance goals and meet deadlines in a fast-paced environment, collaborate, and identify and implement creative solutions to complex problems.
  • Strong learning orientation, curiosity, and commitment to science and patients.

Responsibilities

  • Provide medical direction and scientific and clinical expertise to guide the strategy and execution of pancreatic and colorectal cancer programs and contribute to clinical decision-making across the company portfolio.
  • Lead the clinical development subteam for all studies in gastrointestinal cancers.
  • Design and implement clinical trials with appropriate endpoints.
  • Lead clinical study subteams, monitor overall study integrity, and review, interpret, and communicate safety and efficacy data.
  • Set strategy for clinical aspects of registrational strategies, interactions, and filings; contribute to global regulatory filings and health authority interactions, including authoring clinical sections for INDs, NDAs, and related documents.
  • Serve as medical lead on clinical programs and represent Clinical Development on program teams.
  • Partner with Drug Safety to assess compound safety profiles.
  • Write or partner in authoring medical aspects of core study and regulatory documents, including clinical research plans, protocols, investigator brochures, clinical study reports, and regulatory submissions.
  • Contribute to scientific publications, author manuscripts, and collaborate with cross-functional colleagues and thought leaders to meet publication plan objectives.
  • Present at scientific, medical, and regulatory meetings.
  • Maintain clinical and scientific expertise by reviewing literature, attending medical or scientific meetings, and exchanging knowledge with thought leaders, investigators, internal stakeholders, and partners.
  • Participate in due diligence and other business development activities.
  • Hire, develop, and mentor a high-functioning team of medical directors and clinical scientists.
  • Establish and maintain relationships across the company, particularly with Research and Development partners and stakeholders.
  • Perform duties in accordance with company values, policies, and applicable regulations.

Desired Qualifications

  • Exposure to early development and the transition from first-in-human studies to registrational trials is preferred.
  • A combination of clinical practice, academic clinical trials, and industry experience is desirable; experience in both large and small companies is a plus.

About the Company

Erasca

Clinical-stage oncology company targeting RAS/MAPK pathway

Erasca is a clinical-stage precision oncology company focused on stopping the RAS/MAPK signaling pathway, a major driver in many cancers. Its products aim to block this pathway across multiple modalities to treat a wide range of tumors that rely on RAS/MAPK signaling. The company distinguishes itself by pursuing a comprehensive shutdown of the pathway through diverse therapeutic approaches, targeting cancer patients worldwide and seeking to bring multiple therapeutic programs to approval and commercialization. Its ultimate goal is to eradicate cancer and improve outcomes for millions of patients affected by RAS/MAPK-driven tumors.

Company size
51-200
Company stage
IPO
Headquarters
San Diego, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Erasca

See more jobs